| XENCOR INC. DL-,01 |
| USA |
| Gesundheit |
| US98401F1057 / A1W96L |
| XE9 (Frankfurt) / XNCR (NASDAQ) |
| FRA:XE9, ETR:XE9, XE9:GR, NASDAQ:XNCR |
| - |
| - |
|
Xencor Inc. is a biopharmaceutical company dedicat..
>Volltext.. |
| 477.09 Mio. EUR |
| 281.31 Mio. EUR |
| 125.84 Mio. EUR |
| -114.2 Mio. EUR |
| -146.53 Mio. EUR |
| -2.07 EUR |
| 182.39 Mio. EUR |
| 38.06 Mio. EUR |
| -111.83 Mio. EUR |
| 4.62 |
| -10.95% |
| 18.64% |
| - |
| - |
| - |
| - |
| XENCOR |
| 19.08.25 |
|